Apr 29

Additional secondary efficacy analyzes.

As a physician, I am of the growing problem of opioid addiction, especially prescription opioid abuse, and to treat the challenge effectively our patients with a safe, durable and diversion – resistant treatment in question. Such data could in a dramatic change translate into our treatment options.. Additional secondary efficacy analyzes, including the mean %age of urine samples negative for illicit opioids over treatment weeks 1-16, and the full six-month period also statistically favored Probuphine over placebo Another important measure of effectiveness.

– evaluation of the study, the major secondary endpoint also showed positive results: – treatment with Probuphine resulted in a statistically significant difference in the opioid negative urine samples compared to the placebo treatment over weeks 17-24 than by the cumulative distribution function of the negative urine samples measured.The study also found Michelle M. openly Add Minnesota, 6,946 payments totaling $ 30,000 well known, there were 6,238 payments of $ 100 or greater to physicians. .

The authors believe that the info obtain through insufficiently disclose laws reveals the true pattern of paid. – ‘Making the payments is public, requires stringent laws to clear mechanisms for enforce,’they conclude. 2007, 297:1216-1223).

Please refer to the items for more information including other authors, author Posts and affiliations, financial disclosures, finance and support. Editorial: Sunshine Laws and pharmaceutical industry.